Current fellows
Past fellows
Laura Piccio, MD, PhD
2005 – 2008
FG-1665-A-1 NMSS Post-doctoral Fellow: “Pathogenic and potential therapeutic role of TREM2 in CNS autoimmune inflammatory diseases”
Present position: Professor, Dept. of Neurology, Washington University Sch of Med. And Dept of Neurology, University of Sydney, Australia. Former Harry Weaver Neuroscience Scholar of the NMSS
David Pitt, MD
2005 – 2008
FG 1666-A-1 NMSS Post-doctoral Fellow: “Restoring Glutamate Homeostasis in EAE”
Present position: Associate Professor of Neurology, Yale School of Medicine, New Haven
Peiqing Qian, MD
2010 – 2012
“Pain in Neuromyelitis optica”
Present position: neurologist, Swedish Medical Center Multiple Sclerosis Ctr, Seattle Washington. (R. Naismith primary mentor)
John Rinker II, MD
2005 – 2007
CF-0022N-1: “Immunophenotyping of peripheral blood cells and Cerebrospinal Fluid cells”
Present position: Associate Professor of Neurology, University of Alabama, Birmingham.
Amjad Samara, MD
2022 – 2023
“Examining surface-in gradient using R2t* imaging.”
Present position: current PGY3 neurology resident
Rohini Samudralwar, MD
2017 – 2018
“Fingolimod and Infectious Disease.”
Present position: Assistant Professor at University of Pennsylvania in Philadelphia (Primary mentor: David B. Clifford)
Pascal Sati, PhD
2008 – 2009
“Evaluation of multiple sclerosis lesions using gradient echo plural contrast imaging.”
Present position: Associate Professor and Director of Neuroimaging Program at Cedars-Sinai Los Angeles (Dmitriy Yablonskiy PhD primary mentor)
Afsaneh Shirani, MD
2017 – 2019
“Diffusion Basis Spectrum Imaging in MS patients” funded jointly by NMSS-ABF Clinician Scientist Development Award and American Academy of Neurology
Present position: Assistant Professor of Neurology, Univ Nebraska, Omaha
Jennifer Stark, PhD
2005 – 2007
Kirschstein-NRSA Individual Fellowship Application: “Reg proteins as treatment for CNS inflammatory demyelination”
Present position: Retired. Former position: Director of Research Training Programs, National Multiple Sclerosis Society USA, New York. (deceased Feb 27, 2023)
Miguel Tolentino, PhD
“CSF prognostic factors in MS”